Renaissance Technologies’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-123,100
| Closed | -$1.22M | – | 4446 |
|
|
2023
Q1 | $1.22M | Sell |
123,100
-86,500
| -41% | -$857K | ﹤0.01% | 2344 |
|
|
2022
Q4 | $2.09M | Buy |
209,600
+114,300
| +120% | +$852K | ﹤0.01% | 2039 |
|
|
2022
Q3 | $525K | Sell |
95,300
-19,500
| -17% | -$108K | ﹤0.01% | 2903 |
|
|
2022
Q2 | $419K | Sell |
114,800
-21,900
| -16% | -$104K | ﹤0.01% | 3260 |
|
|
2022
Q1 | $827K | Sell |
136,700
-148,200
| -52% | -$903K | ﹤0.01% | 2856 |
|
|
2021
Q4 | $2.4M | Sell |
284,900
-124,800
| -30% | -$1.09M | ﹤0.01% | 1997 |
|
|
2021
Q3 | $3.71M | Sell |
409,700
-41,800
| -9% | -$359K | ﹤0.01% | 1646 |
|
|
2021
Q2 | $3.66M | Buy |
451,500
+46,500
| +11% | +$319K | ﹤0.01% | 1829 |
|
|
2021
Q1 | $2.23M | Buy |
405,000
+181,200
| +81% | +$896K | ﹤0.01% | 2152 |
|
|
2020
Q4 | $761K | Buy |
223,800
+121,900
| +120% | +$321K | ﹤0.01% | 2633 |
|
|
2020
Q3 | $172K | Buy |
101,900
+8,600
| +9% | +$13K | ﹤0.01% | 3138 |
|
|
2020
Q2 | $153K | Buy |
93,300
+3,900
| +4% | +$7.75K | ﹤0.01% | 3210 |
|
|
2020
Q1 | $172K | Buy |
89,400
+3,500
| +4% | +$9.19K | ﹤0.01% | 3128 |
|
|
2019
Q4 | $245K | Buy |
85,900
+3,800
| +5% | +$11K | ﹤0.01% | 3137 |
|
|
2019
Q3 | $270K | Buy |
82,100
+7,400
| +10% | +$23.4K | ﹤0.01% | 3062 |
|
|
2019
Q2 | $243K | Buy |
74,700
+3,600
| +5% | +$12.8K | ﹤0.01% | 3253 |
|
|
2019
Q1 | $266K | Sell |
71,100
-3,100
| -4% | -$10.8K | ﹤0.01% | 3133 |
|
|
2018
Q4 | $256K | Sell |
74,200
-11,300
| -13% | -$55.8K | ﹤0.01% | 3076 |
|
|
2018
Q3 | $613K | Buy |
85,500
+40,200
| +89% | +$312K | ﹤0.01% | 2783 |
|
|
2018
Q2 | $316K | Buy |
45,300
+10,700
| +31% | +$66.5K | ﹤0.01% | 2951 |
|
|
2018
Q1 | $217K | Buy |
34,600
+12,100
| +54% | +$76.2K | ﹤0.01% | 3164 |
|
|
2017
Q4 | $126K | Buy |
+22,500
| New | +$102K | ﹤0.01% | 3202 |
|
|
2016
Q4 | – | Sell |
-9,610
| Closed | -$173K | – | 3534 |
|
|
2016
Q3 | $173K | Buy |
9,610
+3,181
| +49% | +$42.4K | ﹤0.01% | 3096 |
|
|
2016
Q2 | $77K | Buy |
6,429
+5,160
| +407% | +$77.5K | ﹤0.01% | 3193 |
|
|
2016
Q1 | $18K | Buy |
1,269
+804
| +173% | +$11.2K | ﹤0.01% | 3330 |
|
|
2015
Q4 | $8K | Buy |
+465
| New | +$7.83K | ﹤0.01% | 3244 |
|
|
2015
Q2 | – | Sell |
-141
| Closed | -$27K | – | 3437 |
|
|
2015
Q1 | $27K | Sell |
141
-123
| -47% | -$28.3K | ﹤0.01% | 3109 |
|
|
2014
Q4 | $57K | Buy |
264
+85
| +47% | +$19K | ﹤0.01% | 2862 |
|
|
2014
Q3 | $49K | Sell |
179
-122
| -41% | -$33.1K | ﹤0.01% | 2714 |
|
|
2014
Q2 | $92K | Buy |
+301
| New | +$95.6K | ﹤0.01% | 2673 |
|
Renaissance Technologies's APEN Position: Q2 2023 in Review
Renaissance Technologies sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 123,100 shares — an estimated $1.22M sold.
Renaissance Technologies first reported a position in APEN in Q2 2014 and held it in 30 quarters. The position peaked at $3.71M in Q3 2021. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Renaissance Technologies reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Renaissance Technologies sold 123,100 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $1.22M.
- Renaissance Technologies first reported a position in Apollo Endosurgery, Inc. in Q2 2014 and held it in 30 quarters.
- Renaissance Technologies's Apollo Endosurgery, Inc. position peaked at $3.71M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.